STELIOS PAPADOPOULOS Insider Trading $EXEL EXELIXIS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for STELIOS PAPADOPOULOS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STELIOS PAPADOPOULOS. STELIOS PAPADOPOULOS is Director in BIOGEN INC. ($IDPH) and Director in EXELIXIS, INC. ($EXEL) and Director in BG Medicine, Inc. ($BGMD) and Director in Regulus Therapeutics Inc. ($RGLS) and Director in Eucrates Biomedical Acquisition Corp. ($EUCR).
STELIOS PAPADOPOULOS in EXELIXIS, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of STELIOS PAPADOPOULOS: Director
Holdings: 1,228,897 shares
Current Value: $25,278,411
Latest Transaction: May 13 2021
$EXEL Market Capitalization: $6.19B
$EXEL Previous Close: $20.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of STELIOS PAPADOPOULOS in EXELIXIS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BGMD, IDPH, EUCRW, EXEL, RGLS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 3.38 | 40,000 | 135,200 | 0 | |
| May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 3.13 | 40,000 | 125,200 | 0 | |
| May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 6.30 | 40,000 | 252,000 | 0 | |
| May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | S | 25.01 | 5,473 | 136,880 | 1,288,127 | 1.3 M to 1.3 M (-0.42 %) |
| May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Buy | M | 3.38 | 40,000 | 135,200 | 1,293,600 | 1.3 M to 1.3 M (+3.19 %) |
| May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | S | 25.00 | 5,075 | 126,875 | 1,253,600 | 1.3 M to 1.3 M (-0.40 %) |
| May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Buy | M | 3.13 | 40,000 | 125,200 | 1,258,675 | 1.2 M to 1.3 M (+3.28 %) |
| May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | S | 24.95 | 10,222 | 255,039 | 1,218,675 | 1.2 M to 1.2 M (-0.83 %) |
| May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Buy | M | 6.30 | 40,000 | 252,000 | 1,228,897 | 1.2 M to 1.2 M (+3.36 %) |
| May 22 2020 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Grant | A | 0.00 | 15,538 | 0 | 1,188,897 | 1.2 M to 1.2 M (+1.32 %) |
| May 22 2020 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Grant | A | 0.00 | 15,538 | 0 | 1,188,897 | 1.2 M to 1.2 M (+1.32 %) |
| May 15 2020 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 5.82 | 120,791 | 703,004 | 0 | |
| May 15 2020 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Buy | M | 5.82 | 120,791 | 703,004 | 1,173,359 | 1.1 M to 1.2 M (+11.48 %) |
| May 08 2020 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 5.92 | 15,000 | 88,800 | 0 | |
| May 08 2020 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 4.58 | 30,000 | 137,400 | 0 | |
| May 08 2020 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | S | 25.84 | 45,000 | 1,162,800 | 1,052,568 | 1.1 M to 1.1 M (-4.10 %) |
| May 08 2020 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Buy | M | 5.92 | 15,000 | 88,800 | 1,097,568 | 1.1 M to 1.1 M (+1.39 %) |
| May 08 2020 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Buy | M | 4.58 | 30,000 | 137,400 | 1,082,568 | 1.1 M to 1.1 M (+2.85 %) |
| May 24 2019 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 19.77 | 20,634 | 407,934 | 20,634 | |
| May 24 2019 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Grant | A | 0.00 | 10,317 | 0 | 1,052,568 | 1 M to 1.1 M (+0.99 %) |
| Feb 22 2019 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 4.57 | 15,000 | 68,550 | 0 | |
| Feb 22 2019 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 4.16 | 11,250 | 46,800 | 0 | |
| Feb 22 2019 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | S | 21.25 | 26,250 | 557,813 | 1,042,251 | 1.1 M to 1 M (-2.46 %) |
| Feb 22 2019 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Buy | M | 4.57 | 15,000 | 68,550 | 1,068,501 | 1.1 M to 1.1 M (+1.42 %) |
| Feb 22 2019 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Buy | M | 4.16 | 11,250 | 46,800 | 1,053,501 | 1 M to 1.1 M (+1.08 %) |
| May 24 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 20.50 | 15,874 | 325,417 | 15,874 | |
| May 24 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Grant | A | 0.00 | 7,937 | 0 | 1,042,251 | 1 M to 1 M (+0.77 %) |
| May 24 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 20.50 | 15,874 | 325,417 | 15,874 | |
| May 24 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Grant | A | 0.00 | 7,937 | 0 | 1,042,251 | 1 M to 1 M (+0.77 %) |
| May 07 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 11.66 | 15,000 | 174,900 | 0 | |
| May 07 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | S | 22.15 | 15,000 | 332,250 | 1,034,314 | 1 M to 1 M (-1.43 %) |
| May 07 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Buy | M | 11.66 | 15,000 | 174,900 | 1,049,314 | 1 M to 1 M (+1.45 %) |
| Mar 02 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 7.97 | 15,000 | 119,550 | 0 | |
| Mar 02 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | S | 24.05 | 15,000 | 360,750 | 1,034,314 | 1 M to 1 M (-1.43 %) |
| Mar 02 2018 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Buy | M | 7.97 | 15,000 | 119,550 | 1,049,314 | 1 M to 1 M (+1.45 %) |
| Sep 22 2017 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | S | 25.40 | 10,000 | 254,000 | 0 | 10 K to 0 (-100.00 %) |
| Sep 20 2017 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | S | 27.63 | 127,790 | 3,530,838 | 1,034,314 | 1.2 M to 1 M (-11.00 %) |
| Sep 20 2017 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | S | 27.76 | 72,210 | 2,004,550 | 1,162,104 | 1.2 M to 1.2 M (-5.85 %) |
| May 26 2017 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 19.57 | 11,686 | 228,695 | 11,686 | |
| May 26 2017 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Grant | A | 0.00 | 5,843 | 0 | 1,234,314 | 1.2 M to 1.2 M (+0.48 %) |
| Mar 21 2017 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 10.53 | 10,000 | 105,300 | 0 | |
| Mar 21 2017 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | S | 21.66 | 10,000 | 216,600 | 1,228,471 | 1.2 M to 1.2 M (-0.81 %) |
| Mar 21 2017 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Buy | M | 10.53 | 10,000 | 105,300 | 1,238,471 | 1.2 M to 1.2 M (+0.81 %) |
| May 26 2016 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 6.30 | 40,000 | 252,000 | 40,000 | |
| Jan 05 2016 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Grant | A | 0.00 | 15,071 | 0 | 1,228,471 | 1.2 M to 1.2 M (+1.24 %) |
| May 28 2015 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 3.13 | 40,000 | 125,200 | 40,000 |
Page: 1